SCHEMBL30184507

SCHEMBL30184507

C#CCNc1ccc(P(=O)(CC)CC)cc1OCOC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25033178 1.00 — —
SCHEMBL25030907 0.87 LMNA (0.35) —
SCHEMBL30184470 0.87 LMNA (0.35) —
SCHEMBL30184621 0.86 — —
SCHEMBL25033173 0.86 — —
SCHEMBL25033175 0.77 CA12 (0.33) —
SCHEMBL30184460 0.77 CA12 (0.33) —
SCHEMBL29212272 0.75 CLCN2 (0.30) —
SCHEMBL25033174 0.74 ALDH1A1 (0.40) —
SCHEMBL30184588 0.74 ALDH1A1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400591-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-12-05 — — US disclosed
EP-4384510-A1 COMPOUNDS TARGETING MUTANT OF P53 Jacobio Pharmaceuticals Co., Ltd. (CN) 2024-06-19 — — EP disclosed
CN-117813295-A Compounds targeting p53 mutants 北京加科思新药研发有限公司 2024-04-02 — — CN disclosed
WO-2023016434-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-02-16 — — WO disclosed
Send feedback